VerbatimParliament, as it happens

Blood Cancer: Medical Treatments

Asked by Andrew RosindellReform UKDepartment of Health and Social CareTabled Answered 26 November 2025UIN 92959

The question

To ask the Secretary of State for Health and Social Care, what steps are being taken to improve patient access to clinically effective new blood cancer treatments for NHS patients.

Answered by Dr Zubir Ahmed

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources. NHS England funds NICE-recommended cancer medicines from the Cancer Drugs Fund from the point of positive draft NICE guidance, bringing forward patient access by approximately five months than would otherwise be the case.

For the years 2023/24 to 2024/25, NICE recommended 25 medicines to treat blood cancer that are now available for the treatment of NHS patients.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim